AU5815100A - Therapeutic agents - Google Patents

Therapeutic agents Download PDF

Info

Publication number
AU5815100A
AU5815100A AU58151/00A AU5815100A AU5815100A AU 5815100 A AU5815100 A AU 5815100A AU 58151/00 A AU58151/00 A AU 58151/00A AU 5815100 A AU5815100 A AU 5815100A AU 5815100 A AU5815100 A AU 5815100A
Authority
AU
Australia
Prior art keywords
formula
compound
methyl
lipase inhibitor
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58151/00A
Other languages
English (en)
Inventor
Alan Martin Birch
David John Heal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Abbott GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott GmbH and Co KG filed Critical Abbott GmbH and Co KG
Publication of AU5815100A publication Critical patent/AU5815100A/en
Assigned to ABBOTT GMBH & CO. KG reassignment ABBOTT GMBH & CO. KG Amend patent request/document other than specification (104) Assignors: KNOLL AKTIENGESELLSCHAFT
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU58151/00A 1999-06-24 2000-06-16 Therapeutic agents Abandoned AU5815100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9914742 1999-06-24
GBGB9914742.3A GB9914742D0 (en) 1999-06-24 1999-06-24 Therapeutic agents
PCT/EP2000/005544 WO2001000187A2 (en) 1999-06-24 2000-06-16 Pharmaceutical composition containing sibutramine and a lipase inhibitor

Publications (1)

Publication Number Publication Date
AU5815100A true AU5815100A (en) 2001-01-31

Family

ID=10855953

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58151/00A Abandoned AU5815100A (en) 1999-06-24 2000-06-16 Therapeutic agents

Country Status (20)

Country Link
EP (1) EP1189638A2 (pt)
JP (1) JP2003503344A (pt)
KR (1) KR20020012293A (pt)
CN (1) CN1365287A (pt)
AU (1) AU5815100A (pt)
BG (1) BG106209A (pt)
BR (1) BR0011884A (pt)
CA (1) CA2376213A1 (pt)
CZ (1) CZ20014614A3 (pt)
GB (1) GB9914742D0 (pt)
HK (1) HK1050476A1 (pt)
HU (1) HUP0201880A3 (pt)
IL (1) IL147078A0 (pt)
MX (1) MXPA01013023A (pt)
NO (1) NO20016301D0 (pt)
PL (1) PL352387A1 (pt)
SK (1) SK18822001A3 (pt)
TR (1) TR200103704T2 (pt)
WO (1) WO2001000187A2 (pt)
ZA (1) ZA200110046B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399826B1 (en) * 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
US7089666B2 (en) * 2003-06-06 2006-08-15 The Regents Of The University Of California Microfabricated vertical comb actuator using plastic deformation
JP2010503709A (ja) 2006-09-15 2010-02-04 レビバ ファーマシューティカルズ，インコーポレーテッド シクロアルキルメチルアミンの合成、使用方法および組成物
CN101890017A (zh) * 2009-05-22 2010-11-24 北京奥萨医药研究中心有限公司 含有西布曲明和他汀类降脂药物的药物组合物及其用途
WO2012003501A2 (en) 2010-07-02 2012-01-05 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
US9238625B2 (en) 2011-12-30 2016-01-19 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives

Also Published As

Publication number Publication date
CA2376213A1 (en) 2001-01-04
CZ20014614A3 (cs) 2004-02-18
GB9914742D0 (en) 1999-08-25
PL352387A1 (en) 2003-08-25
JP2003503344A (ja) 2003-01-28
BG106209A (en) 2002-09-30
CN1365287A (zh) 2002-08-21
ZA200110046B (en) 2003-03-06
HUP0201880A3 (en) 2003-03-28
KR20020012293A (ko) 2002-02-15
NO20016301L (no) 2001-12-21
NO20016301D0 (no) 2001-12-21
TR200103704T2 (tr) 2002-05-21
SK18822001A3 (sk) 2003-04-01
EP1189638A2 (en) 2002-03-27
HK1050476A1 (zh) 2003-06-27
BR0011884A (pt) 2003-08-12
HUP0201880A2 (hu) 2002-12-28
WO2001000187A3 (en) 2001-11-15
MXPA01013023A (es) 2003-08-01
IL147078A0 (en) 2002-08-14
WO2001000187A2 (en) 2001-01-04

Similar Documents

Publication Publication Date Title
AU773188B2 (en) Method of treating eating disorders
US6403641B2 (en) Therapeutic agents
WO2001062341A2 (en) Combination product for the treatment of obesity
US6376552B1 (en) Treatment of gallstones
WO2001000205A1 (en) Pharmaceutical composition containing sibutramine and orlistat
AU5815100A (en) Therapeutic agents
AU773490B2 (en) Treatment of osteoarthritis
RU2234917C2 (ru) Терапевтические средства
WO2000056312A1 (en) Treatment of pulmonary hypertension
MXPA00006201A (en) Pharmaceutical composition containing sibutramine and orlistat
WO2000056308A1 (en) Prevention of cardiovascular disease
WO2000056316A1 (en) Treatment of gallstones

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: ABBOTT GMBH AND CO.KG

Free format text: FORMER NAME: KNOLL AKTIENGESELLSCHAFT

MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted